Sumitomo Pharma America Holdings Inc.
The company is a service provider that specializes in the discovery, development, and commercialization of innovative pharmaceutical treatments. It offers vital operational services to the North American Sumitomo Pharma Group affiliates, focusing on transforming challenges into opportunities for growth and innovation. The company emphasizes collaboration, trust, and a commitment to supporting those who serve patients.
Marlborough, United States
Founded in 2009
51-100 Employees
Medium-Sized
Working industry
Other
Type of company
Service provider
Locations
1 Headquarter
Number of services
1 Service
Specialised areas
Pharmaceuticals
Sumitomo Pharma America Holdings Inc. offers a wide range of products and services
Service
Sumitomo Pharma America Holdings, Inc. | Shared Services
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
United States
Overall risk estimation:
Low
The ESG Data of countries are based on public sources
Environment
D
Grade (A-E)
View details
Social
A
Grade (A-E)
View details
Governance
A
Grade (A-E)
View details
Sumitomo Pharma America Holdings Inc. operates in 1 country around the world
Get an overview of the locations of Sumitomo Pharma America Holdings Inc.
Location
Country
State
City
Headquarter
United States
Massachusetts
Marlborough
Some frequent questions that have been asked about Sumitomo Pharma America Holdings Inc.
Where is Sumitomo Pharma America Holdings Inc. located?
The company headquarter of Sumitomo Pharma America Holdings Inc. is located in Marlborough, Massachusetts, United States. It's worth noting, that the company may have more locations
How many employees does Sumitomo Pharma America Holdings Inc. approximately have?
As of the latest available information Sumitomo Pharma America Holdings Inc. has around 51-100 employees worldwide.
When was Sumitomo Pharma America Holdings Inc. founded?
Sumitomo Pharma America Holdings Inc. was founded in 2009
In which industries does Sumitomo Pharma America Holdings Inc. mainly work?
The company Sumitomo Pharma America Holdings Inc. has it's main focus in the industries of Other
What is the current company status of Sumitomo Pharma America Holdings Inc.?
Based on the founding year and the amount of employees the company Sumitomo Pharma America Holdings Inc. seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to Sumitomo Pharma America Holdings Inc.
Sumitomo Pharma Switzerland
Basel, Switzerland
11-50 Employees
2023
Sumitomo Pharma Switzerland GmbH is a biopharmaceutical manufacturer dedicated to accelerating scientific and therapeutic breakthroughs. The company focuses on delivering innovative therapies in critical disease areas, including psychiatry and neurology, oncology, urology, women's health, rare diseases, and cell and gene therapies. Leveraging advanced technologies and a collaborative approach, Sumitomo Pharma aims to meet patient needs effectively and efficiently.
Sepracor Canada (Nova Scotia) Limited
Windsor, Canada
11-50 Employees
1993
Sumitomo Pharma Canada (SMPCA) is an innovative health care company dedicated to improving the health and well-being of patients in Canada. As a manufacturer and commercializer of prescription products, SMPCA focuses on delivering patient-needed therapies for serious medical conditions. The company leverages cutting-edge science and technology to curate innovative treatments, emphasizing research and development services in the healthcare sector. SMPCA is a subsidiary of Sumitomo Pharma America (SMPA).
S & S HEALTHCARE
India
1-10 Employees
2016
S & S HEALTHCARE is a leading pharmaceutical manufacturer dedicated to improving lives through the discovery, development, and distribution of high-quality medications. The company focuses on addressing unmet medical needs and enhancing patient well-being by delivering innovative solutions. Equipped with state-of-the-art facilities and advanced technologies, S & S HEALTHCARE adheres to stringent manufacturing and quality control standards to ensure product integrity, purity, and efficacy. Through collaborations with scientists, academic institutions, and healthcare organizations, the company explores breakthrough therapies while offering patient support programs that provide comprehensive assistance, education, and resources for patients and caregivers.
Gaarnis Pharma
Kochi, India
1-10 Employees
-
Gaarnis Pharma is a pharmaceuticals company based in Kochi, India, focused on identifying and developing breakthrough treatments while finding innovative ways to deliver them to the masses. The company is dedicated to providing high-quality products and services and adheres to the highest ethical standards in its operations. Gaarnis Pharma aims to improve lives by spreading smiles and happiness through its pharmaceutical offerings.
LEIUTIS PHARMACEUTICALS PRIVATE LIMITED
Kallur, India
51-100 Employees
-
LEIUTIS PHARMACEUTICALS PRIVATE LIMITED is a manufacturer of Specialty Nanotherapeutics, focusing on the innovation of high-quality medicines aimed at providing advanced treatment options in specific therapeutic areas. With over two decades of experience in research and product design, the company is dedicated to creating innovative pharmaceutical products that enhance patient quality of life and alleviate symptoms.
Tolero Pharmaceuticals
United States
11-50 Employees
2011
Sumitomo Pharma America (SMPA) is a biopharmaceutical company focused on delivering innovative therapies for critical disease areas, including psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell and gene therapies. With a commitment to accelerating scientific breakthroughs, SMPA operates specialty and oncology business units, developing treatments aimed at improving and extending the lives of patients with severe oncological and hematological diseases. The company is engaged in biotechnology and pharmaceutical manufacturing, contributing to the development of therapies that address complex health challenges.